Gilead Sciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gilead Sciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $2.47 | $2.14 | 15.4 % |
| Q2 | 2025-08-07 | $2.01 | $1.95 | 3.08 % |
| Q1 | 2025-04-24 | $1.81 | $1.76 | 2.84 % |
| Q4 | 2025-02-11 | $1.90 | $1.70 | 11.8 % |
Gilead Sciences (GILD) is scheduled to report earnings on April 23, 2026. The last reported earnings were for reported on October 30, 2025 for Q3.
The Actual EPS was $2.47, which beat the estimate of $2.14.
The Actual Revenue was $7.77B, which beat the estimate of $7.46B.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $7.77B | $7.46B | 4.15 % |
| Q2 | 2025-08-07 | $7.08B | $6.96B | 1.77 % |
| Q1 | 2025-04-24 | $6.67B | $6.77B | -1.52 % |
| Q4 | 2025-02-11 | $7.57B | $7.15B | 5.86 % |